Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nansa Burlet

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Orthopaedics and Related Research|February 8, 2006
Strontium ranelate: the first dual acting treatment for postmenopausal osteoporosisNansa Burlet, Jean-Yves Reginster
Bone|February 4, 2006
Osteoporosis: a still increasing prevalenceJean-Yves Reginster, Nansa Burlet
Women'S Health (London, England)|October 7, 2009
Injectable bisphosphonates for the treatment of osteoporosisJean-Yves Reginster, Nansa Burlet, Pierre Close, et al.
Archives of Public Health = Archives Belges De Sante Publique|December 16, 2015
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fracturesOlivier Ethgen, Mickaël Hiligsmann, Nansa Burlet, et al.
BMC Musculoskeletal Disorders|December 18, 2008
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE systemOlivier Bruyère, Nansa Burlet, Pierre D Delmas, et al.
Arthritis Research & Therapy|December 2, 2015
Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC)Audrey Neuprez, Olivier Bruyère, Emmanuel Maheu, et al.
Vaccines|June 27, 2024
Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in FranceMarc Paccalin, Gaëtan Gavazzi, Quentin Berkovitch, et al.
Expert Review of Vaccines|October 16, 2024
Cost-effectiveness of cell-based influenza vaccine in FranceGaetan Gavazzi, Marc Paccalin, Quentin Berkovitch, et al.
Infectious Diseases and Therapy|June 26, 2020
Communicating Benefits from Vaccines Beyond Preventing Infectious DiseasesEmma-Pascale Chevalier-Cottin, Hayley Ashbaugh, Nicholas Brooke, et al.
Expert Review of Vaccines|February 24, 2016
Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseasesS Rachel Skinner, Dan Apter, Newton De Carvalho, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Orthopaedics and Related Research|February 8, 2006
Strontium ranelate: the first dual acting treatment for postmenopausal osteoporosisNansa Burlet, Jean-Yves Reginster
Bone|February 4, 2006
Osteoporosis: a still increasing prevalenceJean-Yves Reginster, Nansa Burlet
Women'S Health (London, England)|October 7, 2009
Injectable bisphosphonates for the treatment of osteoporosisJean-Yves Reginster, Nansa Burlet, Pierre Close, et al.
Archives of Public Health = Archives Belges De Sante Publique|December 16, 2015
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fracturesOlivier Ethgen, Mickaël Hiligsmann, Nansa Burlet, et al.
BMC Musculoskeletal Disorders|December 18, 2008
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE systemOlivier Bruyère, Nansa Burlet, Pierre D Delmas, et al.
Arthritis Research & Therapy|December 2, 2015
Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC)Audrey Neuprez, Olivier Bruyère, Emmanuel Maheu, et al.
Vaccines|June 27, 2024
Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in FranceMarc Paccalin, Gaëtan Gavazzi, Quentin Berkovitch, et al.
Expert Review of Vaccines|October 16, 2024
Cost-effectiveness of cell-based influenza vaccine in FranceGaetan Gavazzi, Marc Paccalin, Quentin Berkovitch, et al.
Infectious Diseases and Therapy|June 26, 2020
Communicating Benefits from Vaccines Beyond Preventing Infectious DiseasesEmma-Pascale Chevalier-Cottin, Hayley Ashbaugh, Nicholas Brooke, et al.
Expert Review of Vaccines|February 24, 2016
Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseasesS Rachel Skinner, Dan Apter, Newton De Carvalho, et al.
Pageof 3